Literature DB >> 10707004

Microsatellite instability and mutations of E2F-4 in hepatocellular carcinoma from Korea.

.   

Abstract

It has been suggested that genetic changes in cancers are related to genomic instability. To evaluate a possible correlation between growth-regulatory genes and genomic instability in HCC, we investigated microsatellite instability and mutations of TGF-beta type II receptor (TGF-beta RII) and E2F-4 genes in each pair of tumor and surrounding nontumor liver tissues, collected from 19 patients with HCC. By the identification of mutations in six different genetic loci (D1S170, D2S123, D4S395, D13S126, D13S260, and D16S402), one or more alterations in microsatellite markers were identified in 13/19 (68%) hepatocellular carcinoma specimens. When two repeated sequences of TGF-beta RII gene, poly(A)(10) tract in exon 8 and poly(GT)(3) tract in exon 9, were analyzed by polymerase chain reaction-single strand conformational polymorphism, none of the 19 hepatocellular carcinoma specimens showed mutations. When amplicons of poly(AGC)(13) tract of E2F-4 were analyzed by cloning and automated sequencing, 5/19 (36%) hepatocellular carcinomas showed deletion mutation in one or two AGC repeats and such mutations were identified only among cases with microsatellite instability. These results suggest that both microsatellite instability and mutations of E2F-4 occur commonly in hepatocellular carcinoma and play an important role in hepatocarcinogenesis.

Entities:  

Year:  2000        PMID: 10707004     DOI: 10.1016/s1386-6346(99)00066-2

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

1.  Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas.

Authors:  Jingjing Jiao; Weibo Niu; Ying Wang; Keith Baggerly; Yuanqing Ye; Xifeng Wu; Dewitt Davenport; Jose Luis Almeda; Monica M Betancourt-Garcia; R Armour Forse; Heather L Stevenson; Gordon P Watt; Joseph B McCormick; Susan P Fisher-Hoch; Laura Beretta
Journal:  Cancer Prev Res (Phila)       Date:  2017-10-31

Review 2.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

3.  Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.

Authors:  ZhaoHui Xu; Hui Qu; Fan Zhang; YanYing Ren; ZeZhong Gong; Hyok Ju Ri; Shuai Shao; XiaoLiang Chen; Xin Chen
Journal:  Int J Gen Med       Date:  2022-05-11

4.  Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.

Authors:  Yan-Lin Huang; Gang Ning; Lu-Biao Chen; Yi-Fan Lian; Yu-Rong Gu; Jia-Liang Wang; Dong-Mei Chen; Huan Wei; Yue-Hua Huang
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

5.  GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma.

Authors:  Zhenzhen Zou; Yibin Sun; Lin Wang; Sai Ma; Chunrong Sun; Yu Zhou; Guorong Yang
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

Review 6.  Involvement of DNA damage response pathways in hepatocellular carcinoma.

Authors:  Sheau-Fang Yang; Chien-Wei Chang; Ren-Jie Wei; Yow-Ling Shiue; Shen-Nien Wang; Yao-Tsung Yeh
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.